FDA Inspection 1244344 — Anoaneta Tomova

Anoaneta Tomova — FEI 3022575003

The FDA completed an inspection of Anoaneta Tomova on June 27, 2024 in Plovdiv. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 27, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Plovdiv (Bulgaria)

Additional Details

Clinical BA/BE